Perioperative blood transfusion and postoperative mortality
Article Abstract:
Blood transfusions for moderate anemia may not reduce postoperative mortality rates among elderly surgical patients. Researchers compared mortality rates and transfusion patterns for 8,787 patients aged 60 and older who had surgical repair of fractured hips. Most patients with severe anemia were transfused, as were about half with moderate anemia. Transfusions around the time of surgery for hemoglobin levels of 8 milligrams per deciliter or higher did not affect the mortality rates one to three months after surgery. The benefits of blood transfusion in moderate anemia may need reassessment.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Parenteral ketorolac: the risk for acute renal failure
Article Abstract:
Short-term use of ketorolac does not seem to increase the risk for kidney failure compared to opiate medications. The incidence and risk for kidney failure were compared among 9,850 patients treated with ketorolac and 10,145 patients treated with opiate medication. Only 1.1% of either group had kidney failure following treatment. Overall risk for kidney failure and risk during the first five days of treatment was equal for both treatments. However, risk for kidney failure was significantly higher for patients treated with ketorolac longer than five days.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
The effect of antilymphocyte induction therapy on renal allograft survival: a meta-analysis of individual patient-level data
Article Abstract:
Antilymphocyte induction therapy may be beneficial in certain patients to prevent rejection of a kidney transplant. This therapy blocks the immune response that might lead to graft rejection. Researchers evaluated the medical literature on the use of this therapy in kidney transplant recipients. In 628 patients in which this therapy was tried, graft failure during the first two years was less likely in those who received the therapy, but this benefit did not last longer than five years.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Post-operative care of transplant patients. Heart to heart. Life in the balance
- Abstracts: In utero hematopoietic stem cell transplantation: a status report. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow
- Abstracts: Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS. Protease inhibitors
- Abstracts: This I believe ... about the care of human beings. When negligence becomes homicide. 100 years: a nurses' dreaming
- Abstracts: Corporate liability: security and violence. Labor law update